Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Piper Sandler boosted Itron, Inc. (NASDAQ: ITRI) price target from $72 to $91. Piper Sandler analyst Kashy Harrison upgraded the stock from Neutral to Overweight. Itron shares rose 0.01% to close at $73.02 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. cut the price target for Cara Therapeutics, Inc. (NASDAQ: CARA) from $7 to $2.5. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Cara Therapeutics shares fell 48.9% to close at $0.6291 on Monday. See how other analysts view this stock.
- JP Morgan cut the price target for PepsiCo, Inc. (NASDAQ: PEP) from $185 to $176. JP Morgan analyst Andrea Teixeira downgraded the stock from Overweight to Neutral. PepsiCo ...